
GC73447
JBI-589
Also known as [(3R)-3-aminopiperidin-1-yl]-[2-[1-[(4-fluorophenyl)methyl]indol-2-yl]-3-methylimidazo[1,2-a]pyridin-7-yl]methanone
JBI-589 is a non-covalent PAD4 isoform-selective inhibitor with oral bioavailability
ChemicalCAS2308504-22-3MW481.56FormulaC29H28FN5O
- CAS number
- 2308504-22-3
- Molecular weight
- 481.56
- Formula
- C29H28FN5O
- Solubility
- DMSO : 125 mg/mL (259·57 mM; Need ultrasonic)
- InChIKey
- DUVCPNSLXBKGOK-XMMPIXPASA-N
- Catalogue number
- GC73447
- Brand
- GLPBIO
Computed properties PubChem CID 138578805 · XLogP 4.7 · TPSA 68.6 Ų · H-bond donors 1
- XLogP
- 4.7
- TPSA
- 68.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 36
SMILES CC1=C(N=C2N1C=CC(=C2)C(=O)N3CCC[C@H](C3)N)C4=CC5=CC=CC=C5N4CC6=CC=C(C=C6)F
Computed descriptors from PubChem (CID 138578805), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il